Home About us Reports Charts News Custom Company Scan  
Report Charts News
Title Content
Life Sciences
  Metals & Minerals
Public Sector
  Finance Service
  Real Estate
Technology And Media

Tel: 0086-10-82600828
Fax: 0086-10-82601570

 Fuzhou Dongze Medical Device get funded to gain a position in China’s hemodialysis market
CreateTime:2013-11-19 Editor:liaoyan
Text Size:       

Shanghai Bluesail Investment Co. offered to fund RMB 30 million to Fuzhou Dongze Medical Device Co. and hold its 30% share.

Fuzhou Dongze’s primary focus in on Kidney substitute treatment, man-made kidney treatment and in-depth hemodialysis treatment. In 2013, the company expects to reach RMB 33 million of revenue and RMB 4.2 million of net profit. With the funds provided, Dongze Medical plans to win a portion of China’s hemodialysis market by offering innovative hemodialysis product range and clinical treatment service. 

Related Reports
China Blood Product Industry Report, 2020-2027
China Medical Robot Industry Report, 2020-2026
China In Vitro Diagnostic (IVD) Industry Report, 2019-2025
China Aged Care Industry Report, 2019-2025
China Dental Industry Report, 2019-2025
2005-2021 www.researchinchina.com All Rights Reserved 京ICP备05069564号-1